Drug Profile
Research programme: mitochondrial disorders therapeutics - Khondrion
Alternative Names: KG 183; KH 744; KH183Latest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Khondrion
- Class Small molecules
- Mechanism of Action Reactive oxygen species modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Mitochondrial disorders
Most Recent Events
- 21 Sep 2023 Discontinued - Preclinical for Mitochondrial disorders in Netherlands (unspecified route) (Khondrion pipeline; September 2023)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Mitochondrial disorders in Netherlands
- 29 Jul 2016 Preclinical trials in Mitochondrial disorders in Netherlands (unspecified route)